|
Market Closed -
NYSE
00:00:02 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 229.94 USD | -9.05% |
|
-9.06% | -4.54% |
| 10-30 | RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating | MT |
| 10-30 | Citigroup Adjusts Price Target on ResMed to $270 From $240 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 32.34B | |||||
| 258B | |||||
| 163B | |||||
| 150B | |||||
| 60.84B | |||||
| 53.03B |
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
